Delivery Order SPE2DB20D1100-SPE2DB25FA3Q0

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,512.82 firm fixed-price delivery order is for 4,562,195,728 units of sertraline hydrochloride 50 mg tablets, with a completion date of September 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,458.61 firm fixed-price delivery order is for the supply of 500-count bottles of 50mg Sertraline HCL tablets, a generic antidepressant medication. The contract has an ultimate completion date of November 26, 2024 and was awarded on November 25, 2024. It is not designated as a set-aside contract. This delivery...
This federal contract award, valued at $2,131.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $1,931.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sertraline HCL 50 mg tablets. The contract has an ultimate completion date of May 24, 2023. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,815.63 firm fixed-price delivery order is for the procurement of Sertraline HCL 100 mg tablets, a medication used to treat mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.64 firm fixed-price delivery order is for the supply of 4,556,391,802 units of Sertraline HCL 100 mg tablets. The contract has no set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3RDZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $31,957.90 firm fixed-price delivery order covers the supply of 4,564,452 units of 100 mg Sertraline HCL tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999...
This is a $1,085.40 federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order for the supply of 500 count bottles of 100 mg Sertraline HCL tablets. The contract has an ultimate completion date of October 31, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $122,250.25, is for the provision of Sertraline HCL 50 mg tablets, a medication used to treat mental health conditions. The contract is a firm-fixed-price, Indefinite Delivery Contract (IDC) that runs through January 2, 2025. AmerisourceBergen, the prime contractor, has no major...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Sertraline HCL 100 MG Tablets to support federal healthcare programs. The $13,351.71 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that procures medical supplies and equipment. The contract is not designated under any set-aside program, indicating open competition. Amerisourcebergen also holds a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA3Q0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,631.53 firm fixed-price delivery order is for 4,567,102,482 tablets of sertraline hydrochloride 50 mg, a generic medication used to treat mental health conditions.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract has no set-aside designation, indicating open competition. The contract supports a variety of federal medical institutions, including military treatment facilities and veterans' healthcare programs, with essential medications and medical commodities across multiple therapeutic areas.

Generated 5/1/25, 10:04 AM